Samuel S Engel Selected Research

Samuel S Engel Research Topics

Disease

71	Type 2 Diabetes Mellitus (MODY) 01/2022 - 04/2010
29	Hypoglycemia (Reactive Hypoglycemia) 11/2020 - 04/2010
14	Body Weight (Weight, Body) 01/2019 - 07/2011
6	Cardiovascular Diseases (Cardiovascular Disease) 11/2017 - 11/2014
5	Heart Failure 02/2018 - 07/2015
4	Renal Insufficiency (Renal Failure) 10/2020 - 11/2017
4	Infections 11/2019 - 01/2018
4	Chronic Renal Insufficiency 02/2018 - 07/2010
4	Pancreatitis 11/2017 - 01/2013
4	Hyperglycemia 03/2017 - 01/2013
3	Constipation 01/2021 - 04/2010
3	Diabetes Mellitus 11/2020 - 11/2017
3	Stroke (Strokes) 02/2018 - 04/2017
3	Weight Gain 10/2017 - 03/2015
3	Diarrhea 01/2017 - 04/2010
2	Overweight 01/2022 - 01/2022
2	Myocardial Infarction 11/2017 - 04/2017
2	Hypertension (High Blood Pressure) 11/2017 - 01/2017
2	Neoplasms (Cancer) 11/2017 - 01/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2017 - 02/2017
1	Human Influenza (Influenza) 01/2021
1	Back Pain (Backache) 01/2021
1	Nasopharyngitis 01/2021
1	Arthralgia (Joint Pain) 01/2021
1	Insulin Resistance 05/2020
1	Dementia (Dementias) 11/2019
1	Vascular Diseases (Vascular Disease) 10/2018
1	Cardiac Arrhythmias (Arrythmia) 02/2018
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 02/2018
1	Hypovolemia 02/2018
1	Disease Progression 11/2017
1	Eye Diseases (Eye Disease) 11/2017
1	Bone Fractures (Bone Fracture) 11/2017
1	Diabetic Neuropathies (Diabetic Neuropathy) 11/2017
1	Weight Loss (Weight Reduction) 10/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2017
1	Unstable Angina 04/2017
1	Nausea 01/2017
1	Hyperlipidemias (Hyperlipidemia) 01/2017
1	Vomiting 01/2017
1	Abdominal Pain (Pain, Abdominal) 01/2017
1	Edema (Dropsy) 09/2016
1	Albuminuria 09/2016
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2013
1	Dyslipidemias (Dyslipidemia) 01/2013

Drug/Important Bio-Agent (IBA)

50	Sitagliptin Phosphate (Januvia)FDA Link 01/2022 - 04/2010
31	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 04/2010
16	Hypoglycemic Agents (Hypoglycemics)IBA 11/2020 - 07/2010
12	2- (2,5- difluorophenyl)- 5- (2- (methylsulfonyl)- 2,6- dihydropyrrolo(3,4- c)pyrazol- 5(4H)- yl)tetrahydro- 2H- pyran- 3- amineIBA 01/2021 - 11/2015
11	Insulin (Novolin)FDA Link 01/2022 - 11/2012
11	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 03/2015
9	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2017 - 03/2015
6	Pharmaceutical PreparationsIBA 01/2021 - 11/2014
6	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2020 - 09/2013
6	glimepiride (Amarel)FDA LinkGeneric 01/2019 - 06/2011
6	ertugliflozinIBA 01/2019 - 01/2018
3	Sodium-Glucose Transport ProteinsIBA 02/2018 - 02/2018
2	AutoantibodiesIBA 01/2022 - 01/2022
2	ipragliflozinIBA 01/2021 - 01/2021
2	dapagliflozinIBA 10/2020 - 12/2018
2	Hemoglobins (Hemoglobin)IBA 05/2020 - 01/2016
2	Insulin Glargine (Lantus)FDA Link 01/2019 - 06/2015
2	Glipizide (Glucotrol)FDA LinkGeneric 06/2017 - 07/2011
2	CreatinineIBA 09/2016 - 07/2010
2	Glucagon (Glukagon)FDA Link 11/2015 - 10/2013
2	Antihypertensive Agents (Antihypertensives)IBA 11/2014 - 07/2010
2	IncretinsIBA 10/2013 - 04/2010
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 11/2019
1	SodiumIBA 12/2018
1	Blood Glucose (Blood Sugar)IBA 02/2018
1	omega-Chloroacetophenone (Mace)IBA 11/2017
1	Acarbose FDA LinkGeneric 01/2017
1	AlbuminsIBA 09/2016
1	Pioglitazone (Actos)FDA Link 09/2016
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 12/2015
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 11/2015
1	N- ((4- (1- (3- (3,5- dichlorophenyl)- 5- (6- methoxynaphthalen- 2- yl)- 1H- pyrazol- 1- yl)ethyl)phenyl)carbonyl)- beta- alanineIBA 11/2015
1	Glucagon Receptors (Glucagon Receptor)IBA 11/2014
1	Simvastatin (Zocor)FDA LinkGeneric 01/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2013
1	Gliclazide (Diamicron)IBA 06/2011
1	Glyburide (Glibenclamide)FDA LinkGeneric 06/2011
1	LipidsIBA 07/2010
1	2,4-thiazolidinedione (thiazolidinedione)IBA 07/2010
1	Exenatide (Byetta)FDA Link 04/2010
1	Glucagon-Like Peptide-1 ReceptorIBA 04/2010

Therapy/Procedure

23	Glycemic Control 01/2022 - 07/2011
22	Therapeutics 01/2022 - 04/2010
1	Time-to-Treatment 11/2014
1	Length of Stay 02/2013
1	Injections 04/2010